Abstract
Retinoblastoma, the most prevalent pediatric intraocular malignancy, can cause vision loss in children and adults worldwide. Adults may develop uveal melanoma. It is a hazardous tumor that can expand swiftly and destroy the eye and surrounding tissue. Thus, early retinoblastoma screening in children is essential. This work isolated retinal tumor cells, which is its main contribution. Tumors were also staged and subtyped. The methods let ophthalmologists discover and forecast retinoblastoma malignancy early. The approach may prevent blindness in infants and adults. Experts in ophthalmology now have more tools because of their disposal and the revolution in deep learning techniques. There are three stages to the suggested approach, and they are pre-processing, segmenting, and classification. The tumor is isolated and labeled on the base picture using various image processing techniques in this approach. Median filtering is initially used to smooth the pictures. The suggested method’s unique selling point is the incorporation of fused features, which result from combining those produced using deep learning models (DL) such as EfficientNet and CNN with those obtained by more conventional handmade feature extraction methods. Feature selection (FS) is carried out to enhance the performance of the suggested system further. Here, we present BAOA-S and BAOA-V, two binary variations of the newly introduced Arithmetic Optimization Algorithm (AOA), to perform feature selection. The malignancy and the tumor cells are categorized once they have been segmented. The suggested optimization method enhances the algorithm’s parameters, making it well-suited to multimodal pictures taken with varying illness configurations. The proposed system raises the methods’ accuracy, sensitivity, and specificity to 100, 99, and 99 percent, respectively. The proposed method is the most effective option and a viable alternative to existing solutions in the market.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.